Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Malononitrilamide compound prolongs islet xenograft survival in combination with ciclosporin

Nov. 5, 1999

Cantab and Glaxo Wellcome initiate phase II trials for DISC HSV vaccine

Nov. 5, 1999

Brequinar + ciclosporin for islet xenograft rejection: results using a pig-to-rat model

Nov. 4, 1999

Combinations of ERL-080A, RAD and/or ciclosporin prolong heart xenograft survival

Nov. 4, 1999

ImClone receives payment from AHP for gonorrhea vaccine milestone

Nov. 4, 1999

Potential new approach to xenotransplantation: WF-10-containing combinations

Nov. 3, 1999

CA-074: a cathepsin B inhibitor with potential in xenotransplantation

Nov. 3, 1999

Combination of FTY-720 and ciclosporin inhibits pig islet xenograft rejection in rats

Nov. 3, 1999

FDA approves IND for North American Vaccine's Hib vaccine

Nov. 3, 1999

Rigel and Novartis enter collaboration to discover B-cell mediators

Nov. 3, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...